ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New York » Psychiatry

Top Psychiatry Prescribers in New York

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
HORACIO CAPOTE M.D.

Psychiatry

10,016

$2.32M

738
177 are 65+

6%
patients receiving schedule two controlled substances

Avg: 1%

3%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 25%

$232
Average prescription price

Avg: $124

THOMAS HAYS MD

Psychiatry

16,647

$2.19M

728
97 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

18%
prescriptions for brand name drugs

Avg: 25%

$132
Average prescription price

Avg: $124

MARC TARLE M.D.

Psychiatry

10,176

$1.23M

726
366 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

7%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $124

STEVEN FOGELMAN M.D.

Psychiatry

13,610

$1.67M

633
126 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$123
Average prescription price

Avg: $124

MARK SLAVEN MD

Psychiatry

12,729

$1.14M

581
105 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

8%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

16%
prescriptions for brand name drugs

Avg: 25%

$90
Average prescription price

Avg: $124

STEVEN NEWMAN M.D.

Psychiatry

6,301

$649K

552
337 are 65+

2%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$103
Average prescription price

Avg: $124

JOHN NAPOLI PHD

Psychiatry

7,867

$1.19M

544
87 are 65+

9%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$152
Average prescription price

Avg: $124

VALENTIN BRAGIN M.D.

Psychiatry

11,956

$1.35M

539
529 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

70%
prescriptions for brand name drugs

Avg: 25%

$113
Average prescription price

Avg: $124

KISHOR ZINZUVADIA M.D.

Psychiatry

10,554

$1.69M

531
228 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$160
Average prescription price

Avg: $124

ARKADY LEVITAN M.D.

Psychiatry

7,459

$736K

513
367 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 25%

$99
Average prescription price

Avg: $124

SAMPATH NEERUKONDA M.D.

Psychiatry

8,865

$1.23M

511
209 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

24%
prescriptions for brand name drugs

Avg: 25%

$139
Average prescription price

Avg: $124

ALEXANDER PINKUSOVICH MD

Psychiatry

7,116

$1.22M

501
404 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

71%
prescriptions for brand name drugs

Avg: 25%

$171
Average prescription price

Avg: $124

FERNANDO TAVERAS MD

Psychiatry

6,189

$796K

473
219 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 25%

$129
Average prescription price

Avg: $124

DEEPIKA SINGH MD

Psychiatry

4,395

$404K

463
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

6%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

23%
prescriptions for brand name drugs

Avg: 25%

$92
Average prescription price

Avg: $124

LEONID IZRAYELIT MD

Psychiatry

7,734

$937K

461
377 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 25%

$121
Average prescription price

Avg: $124

M. ISMAIL M.D.

Psychiatry

4,737

$531K

445
134 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$112
Average prescription price

Avg: $124

MIKHAIL PRESMAN MD

Psychiatry

6,999

$621K

439
435 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

46%
prescriptions for brand name drugs

Avg: 25%

$89
Average prescription price

Avg: $124

GIOVANNY NUNEZ M.D.

Psychiatry

7,333

$811K

424
180 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

36%
prescriptions for brand name drugs

Avg: 25%

$111
Average prescription price

Avg: $124

KASHINATH PATIL MD

Psychiatry

3,775

$532K

414
136 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

27%
prescriptions for brand name drugs

Avg: 25%

$141
Average prescription price

Avg: $124

ISAK ISAKOV

Psychiatry

6,371

$792K

414
215 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

38%
prescriptions for brand name drugs

Avg: 25%

$124
Average prescription price

Avg: $124

SYED MUSTAFA MD

Psychiatry

6,221

$1.17M

411
78 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$188
Average prescription price

Avg: $124

DAVID DICKOFF M.D.

Psychiatry

2,550

$526K

405
330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

22%
prescriptions for brand name drugs

Avg: 25%

$206
Average prescription price

Avg: $124

PHILIP SALTIEL M.D.

Psychiatry

5,519

$783K

405
325 are 65+

13%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

34%
prescriptions for brand name drugs

Avg: 25%

$142
Average prescription price

Avg: $124

DAVID MOLINA M.D.

Psychiatry

9,259

$1.27M

403
137 are 65+

0%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

11%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

20%
prescriptions for brand name drugs

Avg: 25%

$138
Average prescription price

Avg: $124

RONALD ROSEN MD

Psychiatry

6,654

$317K

399
262 are 65+

3%
patients receiving schedule two controlled substances

Avg: 1%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 3%

25%
prescriptions for brand name drugs

Avg: 25%

$48
Average prescription price

Avg: $124

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank